JP2022535553A5 - - Google Patents
Info
- Publication number
- JP2022535553A5 JP2022535553A5 JP2021571970A JP2021571970A JP2022535553A5 JP 2022535553 A5 JP2022535553 A5 JP 2022535553A5 JP 2021571970 A JP2021571970 A JP 2021571970A JP 2021571970 A JP2021571970 A JP 2021571970A JP 2022535553 A5 JP2022535553 A5 JP 2022535553A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- sequence
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910481112 | 2019-06-04 | ||
| CN201910481112.6 | 2019-06-04 | ||
| PCT/CN2020/094053 WO2020244528A1 (zh) | 2019-06-04 | 2020-06-03 | 一种抗ceacam5的单克隆抗体及其制备方法和用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022535553A JP2022535553A (ja) | 2022-08-09 |
| JP2022535553A5 true JP2022535553A5 (https=) | 2023-06-12 |
Family
ID=73652171
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571970A Pending JP2022535553A (ja) | 2019-06-04 | 2020-06-03 | 抗ｃｅａｃａｍ５モノクローナル抗体、その作製方法およびその使用 |
| JP2021572365A Active JP7554781B2 (ja) | 2019-06-04 | 2020-06-03 | 抗ｃｅａｃａｍ５モノクローナル抗体およびその調製方法およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021572365A Active JP7554781B2 (ja) | 2019-06-04 | 2020-06-03 | 抗ｃｅａｃａｍ５モノクローナル抗体およびその調製方法およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20220242968A1 (https=) |
| EP (1) | EP3981793A4 (https=) |
| JP (2) | JP2022535553A (https=) |
| KR (1) | KR20220016943A (https=) |
| CN (2) | CN113906052B (https=) |
| AU (1) | AU2020289301B2 (https=) |
| BR (1) | BR112021024544A2 (https=) |
| CA (1) | CA3142635A1 (https=) |
| TW (2) | TWI844684B (https=) |
| WO (2) | WO2020244528A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240166760A1 (en) * | 2021-03-08 | 2024-05-23 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | MOLECULES THAT BIND TO CD66e POLYPEPTIDES |
| IL308258A (en) | 2021-05-05 | 2024-01-01 | Immatics Biotechnologies Gmbh | Bma031 antigen binding polypeptides |
| CN115505043A (zh) * | 2021-06-23 | 2022-12-23 | 上海吉倍生物技术有限公司 | 特异性结合糖基化ceacam5的抗体 |
| US20240400715A1 (en) * | 2021-11-05 | 2024-12-05 | Vibrant Pharma Limited | Multispecific antibodies and uses thereof |
| CN116925232A (zh) * | 2022-04-02 | 2023-10-24 | 普米斯生物技术(珠海)有限公司 | 靶向ceacam和cd3的多特异性抗体及其用途 |
| EP4569002A2 (en) * | 2022-08-10 | 2025-06-18 | Merck Sharp & Dohme LLC | Proteins binding nkg2d, cd16, and ceacam5 |
| EP4642810A1 (en) * | 2022-12-28 | 2025-11-05 | Full-Life Technologies HK Limited | Antibodies specifically binding to ceacam5 |
| CN116376920A (zh) * | 2023-03-10 | 2023-07-04 | 中山大学附属第五医院 | Ceacam5靶向的car-t细胞的制备方法及应用 |
| WO2024250925A1 (en) * | 2023-06-05 | 2024-12-12 | Nona Biosciences (Suzhou) Co., Ltd. | Anti-ceacam5 antibodies |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| WO2025257185A1 (en) * | 2024-06-11 | 2025-12-18 | Abcely | Humanized anti-human-carcinoembryonic antigen antibody |
| CN118852441B (zh) * | 2024-08-30 | 2025-12-26 | 四川大学 | 一种抗ceacam5的纳米抗体及其相关应用 |
| CN119409833A (zh) * | 2024-10-25 | 2025-02-11 | 华道(上海)生物医药有限公司 | 一种抗ceacam5和ceacam6双靶向抗体及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| ATE207080T1 (de) | 1991-11-25 | 2001-11-15 | Enzon Inc | Multivalente antigen-bindende proteine |
| DK1621554T4 (da) | 1992-08-21 | 2012-12-17 | Univ Bruxelles | Immunoglobuliner blottet for lette kæder |
| US6005079A (en) | 1992-08-21 | 1999-12-21 | Vrije Universiteit Brussels | Immunoglobulins devoid of light chains |
| ES2162863T3 (es) | 1993-04-29 | 2002-01-16 | Unilever Nv | Produccion de anticuerpos o fragmentos (funcionalizados) de los mismos derivados de inmunoglobulinas de cadena pesada de camelidae. |
| US7273608B2 (en) * | 2004-03-11 | 2007-09-25 | City Of Hope | Humanized anti-CEA T84.66 antibody and uses thereof |
| GB0624500D0 (en) * | 2006-12-07 | 2007-01-17 | Istituto Superiore Di Sanito | A novel passive vaccine for candida infections |
| EP2478110B1 (en) | 2009-09-16 | 2016-01-06 | Immunomedics, Inc. | Class i anti-cea antibodies and uses thereof |
| WO2013054320A1 (en) * | 2011-10-11 | 2013-04-18 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
| DK3199552T3 (da) * | 2012-11-20 | 2020-03-30 | Sanofi Sa | Anti-ceacam5-antistoffer og anvendelser heraf |
| CA2924398A1 (en) * | 2013-11-05 | 2015-05-14 | Immunomedics, Inc. | Humanized anti-ceacam5 antibody and uses thereof |
| CA2874083C (en) * | 2014-12-05 | 2024-01-02 | Universite Laval | Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases |
| TWI632160B (zh) * | 2015-01-16 | 2018-08-11 | 中央研究院 | 具有標的部分及效應部分的分子構建體 |
| PE20171790A1 (es) * | 2015-03-23 | 2017-12-28 | Bayer Pharma AG | Anticuerpos anti-ceacam6 y sus usos |
| AU2016274989A1 (en) * | 2015-06-12 | 2017-11-02 | Immunomedics, Inc. | Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs |
| KR20230148844A (ko) * | 2016-03-29 | 2023-10-25 | 유니버시티 오브 써던 캘리포니아 | 암을 표적하는 키메라 항원 수용체 |
| CN108341876B (zh) * | 2017-01-22 | 2021-06-04 | 中国人民解放军第四军医大学 | 抗人ceacam5单克隆抗体及其制备方法和应用 |
| TWI795415B (zh) * | 2017-07-07 | 2023-03-11 | 日商安斯泰來製藥股份有限公司 | 新穎的抗人類ＣＥＡＣＡＭ５抗體Ｆａｂ片段 |
-
2020
- 2020-06-03 AU AU2020289301A patent/AU2020289301B2/en active Active
- 2020-06-03 JP JP2021571970A patent/JP2022535553A/ja active Pending
- 2020-06-03 CA CA3142635A patent/CA3142635A1/en active Pending
- 2020-06-03 WO PCT/CN2020/094053 patent/WO2020244528A1/zh not_active Ceased
- 2020-06-03 EP EP20818729.4A patent/EP3981793A4/en active Pending
- 2020-06-03 BR BR112021024544A patent/BR112021024544A2/pt unknown
- 2020-06-03 KR KR1020227000006A patent/KR20220016943A/ko active Pending
- 2020-06-03 WO PCT/CN2020/094045 patent/WO2020244526A1/zh not_active Ceased
- 2020-06-03 US US17/596,183 patent/US20220242968A1/en active Pending
- 2020-06-03 CN CN202080040435.2A patent/CN113906052B/zh active Active
- 2020-06-03 US US17/616,399 patent/US20220235142A1/en not_active Abandoned
- 2020-06-03 CN CN202080016653.2A patent/CN113474372B/zh active Active
- 2020-06-03 TW TW109118629A patent/TWI844684B/zh active
- 2020-06-03 TW TW109118591A patent/TW202100560A/zh unknown
- 2020-06-03 JP JP2021572365A patent/JP7554781B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022535553A5 (https=) | ||
| US12583933B2 (en) | Anti-CD73 antibody and use thereof | |
| JP7202185B2 (ja) | 抗ｃｄ３抗体及び該抗体を含む分子 | |
| JP2022515318A5 (https=) | ||
| JP2022526764A5 (https=) | ||
| JP2021531005A5 (https=) | ||
| JP2021522801A5 (https=) | ||
| JP2020527332A5 (https=) | ||
| RU2017145150A (ru) | Антитело против pdl-1, его фармацевтическая композиция и применение | |
| JP2025514636A5 (https=) | ||
| JP2020514310A5 (https=) | ||
| WO2024051796A1 (en) | Albumin binding proteins, fusion proteins and uses thereof | |
| JP2023543152A5 (https=) | ||
| RU2019107134A (ru) | Анти-pd-1 антитела | |
| RU2019104980A (ru) | Анти-icos антитела | |
| JP2022532173A5 (https=) | ||
| JP2024540148A5 (https=) | ||
| JP2025512119A5 (https=) | ||
| JP2023517754A5 (https=) | ||
| JP2024532836A5 (https=) | ||
| JP2025503229A5 (https=) | ||
| JP2024516843A5 (https=) | ||
| CN114616245B (zh) | 一种抗cd38的抗体及其用途 | |
| JP2026506070A (ja) | 抗ｃｎｔｎ４抗体及びその使用 | |
| JP2025513767A5 (https=) |